Defibrillation Testing During Defibrillator Implantation.

Area of Science:

• Cardiology
• Medical Devices
• Electrophysiology

Background:

• Implantable cardioverter defibrillators (ICDs) are crucial for managing sudden cardiac death (SCD) by terminating ventricular tachycardia (VT) and ventricular fibrillation (VF).
• Historically, defibrillation testing has been integral to ICD trials to ensure device efficacy and proper function.
• Current ICDs demonstrate high shock efficacy (80-90%) and multiple rescue shocks, suggesting a low failure probability.

Purpose of the Study:

• To evaluate the necessity of defibrillation testing in ICD implantation.
• To determine if abandoning defibrillation testing impacts the mortality benefit of ICD therapy.
• To assess potential harms associated with defibrillation testing.

Main Methods:

• Analysis of data from prospective trials investigating ICD therapy.
• Focus on trials that included defibrillation testing to establish baseline efficacy.
• Comparison of outcomes in patients with and without defibrillation testing.

Main Results:

• Prospective data demonstrating non-inferiority of ICD implantation without defibrillation testing is currently lacking.
• Two major trials (SIMPLE and NORDIC) are ongoing to address this knowledge gap, with expected completion in 2013/14.
• The probability of ICD failure to terminate VT/VF is considered low based on current device capabilities.

Conclusions:

• The abandonment of defibrillation testing requires robust prospective data to ensure patient safety and maintain therapeutic benefits.
• Ongoing trials are critical for establishing guidelines on whether defibrillation testing can be omitted.
• The findings will inform clinical practice regarding ICD implantation protocols and patient management.